CAFs located at the invasive tumor front (CAFs-F), characterized by higher expression of the fibroblast activation marker SMA, were found to secrete elevated levels of microfibril-associated protein 5 (MFAP5) in comparison to NFs and the superficial tumor (CAFs-S) (62). The gene discussed is MFAP5; the disease is neoplasm.